Information displayed below is a subset of the entire knowledge base and may be incorrect, or incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.
3-methylcrotonyl-CoA carboxylase deficiency is an inherited disorder that affects the body's ability to break down certain proteins. It is caused by a deficiency in the enzyme 3-methylcrotonyl-CoA carboxylase, which is responsible for the breakdown of the amino acid leucine. People with this disorder have an accumulation of 3-methylcrotonyl-CoA in their bodies, which can lead to a variety of symptoms, including intellectual disability, seizures, and movement disorders. Treatment typically involves dietary changes and supplementation with carnitine, which helps to break down the 3-methylcrotonyl-CoA.
All of the following must be considered when interpreting
clinical findings and are too extensive to be covered on
this site: